“Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer” has been added to your cart. View cart
Article: Summary of the BVAC/ABCA program hosted by the general annual meeting of the BHS in Ghent, Friday January 25 2013
Summary of the BVAC/ABCA program hosted by the general annual meeting of the BHS in Ghent, Friday January 25 2013
Reviews
There are no reviews yet.
Be the first to review “Article: Summary of the BVAC/ABCA program hosted by the general annual meeting of the BHS in Ghent, Friday January 25 2013” Cancel reply
Reviews
There are no reviews yet.